GM debate lost in EU

By Colin Bettles

BAYER board member Kemal Malik has painted a gloomy picture about the state of play in Europe for Genetically Modified cropping and the technology’s future.

Mr Malik is responsible for innovation with a budget of 4 billion Euro per year (AU$5.9b) on Research and Development in the company’s core business areas including human health and crop protection.

In a wide ranging interview last week, he said Europe’s consumer rejection of GM crops and foods was an emotional reaction that sharply contradicted scientific acceptance of proven medical and human health benefits of genetic modification.